Cargando…
Hydroxychloroquine and QTc prolongation in patients with COVID-19: A systematic review and meta-analysis
BACKGROUND: Among many drugs that hold potential in COVID-19 pandemic, chloroquine (CQ), and its derivative hydroxychloroquine (HCQ) have generated unusual interest. With increasing usage, there has been growing concern about the prolongation of QTc interval and Torsades de Pointes (TdP) with HCQ, e...
Autores principales: | Agstam, Sourabh, Yadav, Ashutosh, Kumar-M, Praveen, Gupta, Ankur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563579/ https://www.ncbi.nlm.nih.gov/pubmed/33075484 http://dx.doi.org/10.1016/j.ipej.2020.10.002 |
Ejemplares similares
-
Which QTc correction formulae (Bazett, Framingham, or Fridericia) to use for Hydroxychloroquine induced QTc prolongation?
por: Gupta, Anunay, et al.
Publicado: (2020) -
Hydroxychloroquine: QTc prolongation: case report.
Publicado: (2020) -
Cardiovascular manifestations of COVID-19: An evidence-based narrative review
por: Sharma, Yash Paul, et al.
Publicado: (2021) -
Hydroxychloroquine: QTc prolongation: 2 case reports
Publicado: (2021) -
Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2020)